3-Bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine

Catalog No. :
ACPUMQ526
CAS No. :
1256822-80-6
Molecular Formula :
C6H3BrFN3
Molecular Weight :
216.01

IUPAC Name:3-bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine

3-Bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$99.00Login to see priceIn stockInquiry
1g95%$252.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine
IUPAC Name3-bromo-5-fluoro-1H-pyrazolo[3,4-b]pyridine
MDL No.MFCD18261249
Molecular FormulaC6H3BrFN3
Molecular Weight216.01
SMILESFC1=CN=C(NN=C2Br)C2=C1
InChI KeyQKRFTNZERDLUQL-UHFFFAOYSA-N
Synonym3-BROMO-5-FLUORO-1H-PYRAZOLO[3,4-B]PYRIDINE | 1256822-80-6 | 3-bromo-5-fluoro-2H-pyrazolo[3,4-b]pyridine | MFCD18261249 | SCHEMBL14685108 | AS-42556 | SY243059 | CS-0051467 | 1H-Pyrazolo[3,4-b]pyridine, 3-bromo-5-fluoro-
CAS No.1256822-80-6
PubChem CID71251254

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPUMQ526 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSLCT870 route compound structure diagram
    ACSLCT8701034667-22-5 In Stock
  4. Then
  5. ACPUMQ526 route product structure diagram
    ACPUMQ5261256822-80-6 In Stock
Inquiry

2. ACPUMQ526 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACSLCT870 route compound structure diagram
    ACSLCT8701034667-22-5 In Stock
  6. Then
  7. ACPUMQ526 route product structure diagram
    ACPUMQ5261256822-80-6 In Stock
Inquiry

Comments (0)